Mesoblast raises new capital for RYONCIL commercial launch
Filed with ASX · · 2 pages · English
Story so far
Earlier from Mesoblast
Later from Mesoblast
- Ryoncil Commercial Launch Update and Product Pipeline
- Dr. Gregory George MD PhD Joins Mesoblast Board
- Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
- Ryoncil Pricing Set and Available This Quarter
- Arcadium Lithium PLC to be removed from the S&P/ASX 200
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast